Lifeward LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
LFWD
Lifeward LTDOramed Pharmaceuticals has filed a Schedule 13D reporting a 49.9% beneficial ownership stake in Lifeward Ltd. following the acquisition of Oratech Pharma and a private placement of convertible notes.